DanCann Pharma Feed

	Tid*
2024-12-10	-	Extra Bolagsstämma 2024
2024-11-22	-	Kvartalsrapport 2024-Q3
2024-08-14	-	Kvartalsrapport 2024-Q2
2024-06-01	-	Kvartalsrapport 2024-Q1
2024-05-30	-	Årsstämma
2024-04-22	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2024-02-28	-	Bokslutskommuniké 2023
2023-11-30	-	Kvartalsrapport 2023-Q3
2023-08-31	-	Kvartalsrapport 2023-Q2
2023-05-31	-	Kvartalsrapport 2023-Q1
2023-04-19	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2023-04-18	-	Årsstämma
2023-02-28	-	Bokslutskommuniké 2022
2022-11-04	-	Kvartalsrapport 2022-Q3
2022-09-20	-	Extra Bolagsstämma 2022
2022-08-31	-	Kvartalsrapport 2022-Q2
2022-05-18	-	Kvartalsrapport 2022-Q1
2022-04-27	-	Årsstämma
2022-04-08	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2022-02-25	-	Bokslutskommuniké 2021
2021-11-26	-	Kvartalsrapport 2021-Q3
2021-08-27	-	Kvartalsrapport 2021-Q2
2021-07-23	-	Extra Bolagsstämma 2021
2021-05-28	-	Kvartalsrapport 2021-Q1
2021-04-29	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2021-04-28	-	Årsstämma
2021-02-26	-	Bokslutskommuniké 2020

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Läkemedel & Handel

2024-12-10 14:15:00 DanCann Pharma A/S: DanCann Pharma Announces Outcome of Directed Issues to Board and Management 0,00 DKK | +14,29% | 0,35 MDKK

2024-12-10 14:00:00 DanCann Pharma A/S: Minutes of Extraordinary General Meeting 0,00 DKK | +14,29% | 0,35 MDKK

2024-11-29 08:00:00 DanCann Pharma A/S: Agreement Reached on Permanent Medicinal Cannabis Scheme in Denmark 0,01 DKK | +11,63% | 1,53 MDKK

2024-11-25 10:20:00 DanCann Pharma A/S Recommends Experienced Politician and Senior Government Official to Join the Board of Directors 0,01 DKK | -13,79% | 5,25 MDKK

2024-11-25 10:15:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S 0,01 DKK | -13,79% | 5,25 MDKK

2024-11-25 08:00:00 DanCann Pharma A/S: The Board of Directors has resolved on directed share issues of DKK 4.5 million and proposal of directed share issues of DKK 0.4 million 0,01 DKK | -13,79% | 5,25 MDKK

2024-11-22 17:30:00 DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients

2024-11-19 09:30:00 DanCann Pharma A/S: The Danish Government Proposes Permanent Scheme for Prescription-Based Medicinal Cannabis for Danish Patients 0,01 DKK | +47,06% | 0,71 MDKK

2024-11-05 17:30:00 DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed 0,00 DKK | -5,26% | 0,05 MDKK

2024-10-07 12:30:00 DanCann Pharma: Minutes of extraordinary general meeting 0,00 DKK | -4,00% | 0,07 MDKK

2024-09-24 16:00:00 DanCann Pharma A/S: Calls for an Extraordinary General Meeting regarding New Authorizations and Reduction of Share Capital in Preparation for Reverse Stock Split 0,01 DKK | -10,34% | 0,19 MDKK

2024-09-20 18:00:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

2024-09-18 12:00:00 DanCann Pharma A/S: Number of Reported Suspected Adverse Reactions Drops by Two-Thirds in 2023 Despite 72% Growth in the Medicinal Cannabis Pilot Programme 0,01 DKK | +2,78% | 0,05 MDKK

2024-08-14 08:15:00 DanCann Pharma A/S: Quarterly CEO Reflection 0,01 DKK | +44,44% | 1,20 MDKK

2024-08-14 08:00:00 DanCann Pharma A/S Publishes Q2-2024 Report: Record Revenue and First-Ever Positive EBITDA 0,01 DKK | +44,44% | 1,20 MDKK

2024-07-03 08:00:00 DanCann Pharma A/S announces last day for trading in temporary shares 0,04 DKK | +1,51% | 0,11 MDKK

2024-06-27 18:45:00 DanCann Pharma A/S announces outcome of the Rights Issue 0,04 DKK | +7,89% | 0,06 MDKK

2024-06-19 12:00:00 DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank 0,05 DKK | +13,24% | 0,11 MDKK

2024-06-18 13:00:00 DanCann Pharma A/S: Solid growth in the Rx portfolio 0,04 DKK | +23,64% | 0,06 MDKK

2024-06-14 09:00:00 DanCann Pharma A/S: Germany trends - prescriptions for medicinal cannabis positively influenced by new legalization 0,04 DKK | -14,88% | 0,10 MDKK

2024-06-12 09:00:00 DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio 0,05 DKK | 0,00% | 0,14 MDKK

2024-06-11 08:00:00 DanCann Pharma A/S: The subscription period of DanCann Pharma's Rights Issue begins today 0,05 DKK | -26,93% | 0,38 MDKK

2024-06-01 19:30:00 DanCann Pharma A/S: Publishes Q1-2024 Report

2024-05-30 12:15:00 DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING 0,01 DKK | +18,01% | 0,06 MDKK

2024-05-24 10:15:00 DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum 0,02 DKK | -10,06% | 0,05 MDKK

2024-05-16 20:30:00 DanCann Pharma A/S: Capital reduction completed 0,02 DKK | -7,14% | 0,05 MDKK

2024-05-15 22:15:00 DanCann Pharma: NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S 0,02 DKK | -12,50% | 0,26 MDKK

2024-05-15 22:00:00 DanCann Pharma A/S Publishes Its Annual Report for 2023: A Year of Strategic Review and Future Focus on Capital Efficiency and Profitability 0,02 DKK | -12,50% | 0,26 MDKK

2024-05-15 18:00:00 DanCann Pharma A/S: Updated time plan and material terms of the rights issue 0,02 DKK | -12,50% | 0,26 MDKK

2024-04-17 12:00:00 DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING 0,01 DKK | +0,82% | 0,01 MDKK

2024-04-02 22:30:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S 0,01 DKK | -5,03% | 0,08 MDKK

2024-03-30 10:15:00 Correction: DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure 0,04 DKK | -47,77%

2024-03-29 13:00:00 DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure 0,04 DKK | -47,77%

2024-02-28 10:30:00 DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization 0,01 DKK | +13,86% | 0,34 MDKK

2024-02-28 08:30:00 DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results 0,01 DKK | +13,86% | 0,34 MDKK

2024-01-10 22:30:00 DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 0,01 DKK | 0,00% | 0,10 MDKK

2023-12-20 09:00:00 DanCann Pharma A/S delivers annual shareholder letter and investor update 0,01 DKK | -3,85% | 0,03 MDKK

2023-11-30 18:10:00 DanCann Pharma A/S: Flagging announcement 0,01 DKK | +2,22% | 0,04 MDKK

2023-11-30 18:00:00 DanCann Pharma A/S publishes Q3-2023 report 0,01 DKK | +2,22% | 0,04 MDKK

2023-11-28 22:00:00 DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1 0,01 DKK | 0,00% | 0,02 MDKK

2023-11-22 21:30:00 DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 0,01 DKK | -14,58% | 0,05 MDKK

2023-10-26 17:30:00 DanCann Pharma A/S: Future strategic direction 0,02 DKK | -7,35% | 0,06 MDKK

2023-10-04 08:00:00 DanCann Pharma A/S Completes Issuance (5) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 0,03 DKK | -8,16% | 0,18 MDKK

2023-10-02 13:00:00 DanCann Pharma A/S sigter mod at accelerere forretnings- og indtægtsvækst: Omfattende strategiopdatering følger i oktober 0,03 DKK | +31,71% | 0,25 MDKK

2023-10-02 13:00:00 DanCann Pharma A/S aims to accelerate business and revenue growth: Comprehensive strategy update to follow in October 0,03 DKK | +31,71% | 0,25 MDKK

2023-09-26 08:45:00 DanCann Pharma A/S Completes Issuance (4) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 0,02 DKK | +2,67% | 0,02 MDKK

2023-08-31 21:00:00 DanCann Pharma A/S Completes Issuance (3) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2 0,02 DKK | -25,93% | 0,38 MDKK

2023-08-31 17:30:00 DanCann Pharma A/S publishes Q2-2023 report 0,02 DKK | -25,93% | 0,38 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

DanCann Pharma

Kalender

Beskrivning

DanCann Pharma

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden